Emergent BioSolutions Shares Are Trading Higher After the Company Announced It Evaluated the Safety and Efficacy of Its New Clinical Trial of Brincidofovir in Treating Mpox Across Africa. PANTHER Will Conduct a Clinical Trial Under The Leadership of...

Emergent BioSolutions股價上漲，因公司宣佈評估其在整個非洲治療MPoX的新BPPVir臨床試驗的安全性和有效性。 PANTHER將在...的領導下進行臨床試驗。

Benzinga · 11/07 21:50

Emergent BioSolutions Shares Are Trading Higher After the Company Announced It Evaluated the Safety and Efficacy of Its New Clinical Trial of Brincidofovir in Treating Mpox Across Africa. PANTHER Will Conduct a Clinical Trial Under The Leadership of Africa Centres for Disease Control and Prevention

Emergent biosolutions股價上漲，公司宣佈評估了其在非洲範圍內治療小百合病毒的新臨床試驗的安全性和有效性。 PANTHER將在非洲疾病控制與預防中心的領導下進行臨床試驗。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。